Literature DB >> 16505648

Candida as a risk factor for mortality in peritonitis.

Philippe Montravers1, Hervé Dupont, Remy Gauzit, Benoit Veber, Christian Auboyer, Patrick Blin, Christophe Hennequin, Claude Martin.   

Abstract

OBJECTIVE: The clinical significance of Candida cultured from peritoneal fluid specimens remains a matter of debate. None of the studies that have addressed this issue have clearly distinguished between community-acquired peritonitis and nosocomial peritonitis. The current study tried to differentiate the pathogenic role of Candida in these two clinical settings and assess its importance on outcome.
DESIGN: A multiple-center, retrospective, case-control study was conducted in intensive care unit patients. The interaction between mortality rates and type of patients was assessed. In the case of a significant interaction, a separate analysis of mortality and morbidity was planned.
SETTING: Seventeen intensive care units in teaching and nonteaching hospitals. PATIENTS: Cases were patients operated on for peritonitis with Candida cultured from the peritoneal fluid, whereas controls were operated patients free from yeast. Cases and controls were matched for type of infection, Simplified Acute Physiology Score II, age, and time period of hospitalization.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The following characteristics were collected: demographic variables, underlying disease, severity score, site of infection, microbiological features, and anti-infective treatments. Survival was defined as the main outcome criterion and morbidity variables as secondary criteria. Odds ratios of mortality were calculated. Matching was achieved in 91 cases and 168 controls. Matching criteria, clinical characteristics, and mortality rate were not statistically different between cases and controls. A significant interaction was demonstrated between mortality rates and type of infection, leading to separate analysis of patients with community-acquired peritonitis and nosocomial peritonitis. The subgroup analysis demonstrated an increased mortality rate only in nosocomial peritonitis with fungal isolates (48% vs. 28% in controls, p<.01). Upper gastrointestinal tract site (odds ratio, 4.9; 95% confidence interval, 1.6-14.8) and isolation of Candida species (odds ratio, 3.0; 95% confidence interval, 1.3-6.7, p<.001) were found to be independent risk factors of mortality in nosocomial peritonitis patients.
CONCLUSIONS: Isolation of Candida species appears to be an independent risk factor of mortality in nosocomial peritonitis but not in community-acquired peritonitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505648     DOI: 10.1097/01.CCM.0000201889.39443.D2

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  71 in total

Review 1.  Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.

Authors:  Dirk Vogelaers; Stijn Blot; Andries Van den Berge; Philippe Montravers
Journal:  Drugs       Date:  2021-05-26       Impact factor: 9.546

Review 2.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

3.  Identification of Specific Components of the Eicosanoid Biosynthetic and Signaling Pathway Involved in Pathological Inflammation during Intra-abdominal Infection with Candida albicans and Staphylococcus aureus.

Authors:  Mélanie A C Ikeh; Paul L Fidel; Mairi C Noverr
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

Review 4.  [Antimicrobial and antimycotic therapy of intra-abdominal infections].

Authors:  P Kujath; M Hoffmann; A Rodloff
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

5.  Prognostic factors in critically ill patients suffering from secondary peritonitis: a retrospective, observational, survival time analysis.

Authors:  Christian P Schneider; Carol Seyboth; Markus Vilsmaier; Helmut Küchenhoff; Benjamin Hofner; Karl-Walter Jauch; Wolfgang H Hartl
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

6.  Letter to editor: "Gastric fistula after laparoscopic sleeve gastrectomy: don't forget to treat for Candida".

Authors:  Lionel Rebibo; Hervé Dupont; Mélanie Levrard; Cyril Cosse; Abdennaceur Dhahri; Pierre Verhaeghe; Jean-Marc Regimbeau
Journal:  Obes Surg       Date:  2013-12       Impact factor: 4.129

7.  Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.

Authors:  Philippe Montravers; Herve Dupont; Philippe Eggimann
Journal:  Intensive Care Med       Date:  2013-10-24       Impact factor: 17.440

8.  Postoperative Peritonitis After Digestive Tract Surgery: Surgical Management and Risk Factors for Morbidity and Mortality, a Cohort of 191 Patients.

Authors:  Thierry Bensignor; Jérémie H Lefevre; Ben Creavin; Najim Chafai; Thomas Lescot; Thévy Hor; Clotilde Debove; François Paye; Pierre Balladur; Emmanuel Tiret; Yann Parc
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

Review 9.  [Update: invasive fungal infections: Diagnosis and treatment in surgical intensive care medicine].

Authors:  C Lichtenstern; S Swoboda; M Hirschburger; E Domann; T Hoppe-Tichy; M Winkler; C Lass-Flörl; M A Weigand
Journal:  Anaesthesist       Date:  2010-01       Impact factor: 1.041

10.  Bacterial species-specific hospital mortality rate for intra-abdominal infections.

Authors:  Jeffrey A Claridge; Aman Banerjee; Katherine B Kelly; William H Leukhardt; Jeffrey W Carter; Manjunath Haridas; Mark A Malangoni
Journal:  Surg Infect (Larchmt)       Date:  2014-05-06       Impact factor: 2.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.